NYSE · Healthcare
Prestige Consumer Healthcare Inc. (PBH)
As-reported financials and recent SEC filings for Prestige Consumer Healthcare Inc., latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.09B
Net income
$190.3M
Net margin
17.5%
Diluted EPS
$3.91
ROE
10.1%
P/E (TTM)
12.6×
Market cap
$2.34B
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Gross profit | $595.6M | $634.5M | $624.4M | $625.3M | $620.6M |
| Operating income | $309.4M | $336.8M | $342.4M | $-22.4M | $329.9M |
| Net income | $190.3M | $214.6M | $209.3M | $-82.3M | $205.4M |
| Diluted EPS | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-16
View on EDGAR →10-K2026-05-14
View on EDGAR →4/A2026-05-14
View on EDGAR →8-K2026-05-13
View on EDGAR →42026-05-12
View on EDGAR →1442026-05-11
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →Go deeper on PBH
Search Prestige Consumer Healthcare Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.